Healthcare provider profile · identity verified

Maureen P Bruns, MD

Internal Medicine · PORTLAND, OR · NPI 1588045702

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	427	77
Eliquis	Apixaban	309	43
Levothyroxine Sodium	Levothyroxine Sodium	295	57
Furosemide	Furosemide	255	52
Amlodipine Besylate	Amlodipine Besylate	241	42
Gabapentin	Gabapentin	224	42
Lisinopril	Lisinopril	222	43
Oxycodone Hcl	Oxycodone Hcl	204	58
Trazodone Hcl	Trazodone Hcl	198	42
Sertraline Hcl	Sertraline Hcl	171	25
Tamsulosin Hcl	Tamsulosin Hcl	167	29
Quetiapine Fumarate	Quetiapine Fumarate	151	22
Duloxetine Hcl	Duloxetine Hcl	140	15
Potassium Chloride	Potassium Chloride	140	34
Metoprolol Succinate	Metoprolol Succinate	120	33
Losartan Potassium	Losartan Potassium	112	29
Clopidogrel	Clopidogrel Bisulfate	110	18
Levetiracetam	Levetiracetam	105	21
Pantoprazole Sodium	Pantoprazole Sodium	101	22
Metformin Hcl	Metformin Hcl	97	16
Mirtazapine	Mirtazapine	96	18
Escitalopram Oxalate	Escitalopram Oxalate	92	20
Alendronate Sodium	Alendronate Sodium	91	14
Torsemide	Torsemide	91	21
Carvedilol	Carvedilol	87	20
Jardiance	Empagliflozin	84	12
Citalopram Hbr	Citalopram Hydrobromide	83	16
Baclofen	Baclofen	69	11
Divalproex Sodium	Divalproex Sodium	67	suppressed
Memantine Hcl	Memantine Hcl	67	11
Olanzapine	Olanzapine	67	13
Donepezil Hcl	Donepezil Hcl	63	suppressed
Allopurinol	Allopurinol	61	13
Famotidine	Famotidine	61	12
Spironolactone	Spironolactone	54	14
Metformin Hcl Er	Metformin Hcl	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	52	12
Omeprazole	Omeprazole	52	suppressed
Xarelto	Rivaroxaban	52	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	47	16
Sodium Chloride	0.9 % Sodium Chloride	47	suppressed
Pregabalin	Pregabalin	44	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Januvia	Sitagliptin Phosphate	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Ondansetron Hcl	Ondansetron Hcl	37	23
Warfarin Sodium	Warfarin Sodium	34	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	16
Oxycontin	Oxycodone Hcl	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Propranolol Hcl	Propranolol Hcl	32	suppressed
Topiramate	Topiramate	32	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	suppressed
Fluticasone Propionate	Fluticasone Propionate	31	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	29	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Lorazepam	Lorazepam	28	13
Primidone	Primidone	28	suppressed
Finasteride	Finasteride	27	suppressed
Nystatin	Nystatin	27	15
Loperamide	Loperamide Hcl	26	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	20
Risperidone	Risperidone	26	suppressed
Gilenya	Fingolimod Hcl	25	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Lamotrigine	Lamotrigine	23	suppressed
Memantine Hcl Er	Memantine Hcl	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Simvastatin	Simvastatin	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Morphine Sulfate	Morphine Sulfate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Prednisone	Prednisone	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Fentanyl	Fentanyl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Zenpep	Lipase/Protease/Amylase	17	suppressed
Bupropion Hcl	Bupropion Hcl	16	suppressed
Cefadroxil	Cefadroxil	16	12
Creon	Lipase/Protease/Amylase	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Atenolol	Atenolol	15	suppressed
Cephalexin	Cephalexin	15	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Clobetasol Emollient	Clobetasol Propionate/Emoll	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Glipizide	Glipizide	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	12	suppressed
Diltiazem Hcl	Diltiazem Hcl	12	suppressed
Haloperidol	Haloperidol	12	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	12	suppressed
Letrozole	Letrozole	12	suppressed
Lidocaine Hcl	Lidocaine Hcl	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Perphenazine	Perphenazine	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Lactulose	Lactulose	11	suppressed
Movantik	Naloxegol Oxalate	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Valproic Acid	Valproic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error